Ensoma
The future of medicine lies within us.
United States · $258.0M raised
- Business Model
- Biotech R&D
- Website
- ensoma.com
- Total Funding
- $258.0M
- Last Round
- $53.0M Venture RoundSep 2025
- Rounds
- 4
About
Genomic medicine company engineering hematopoietic stem cells in vivo to develop durable therapeutic treatments.
Summary
Ensoma is a Biotech company based in United States. It has raised $258.0M in total across 4 rounds, most recently a $53.0M Venture Round round in Sep 2025. Investors include 5AM Ventures, Arix Bioscience and Kite Pharma.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Sep 2025
Sign up to see all 4 rounds
Series A through Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Genomics and data analytics company providing drug discovery and development services to global b...
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ensoma"><img src="https://indexed.vc/api/badge/company/ensoma" alt="Ensoma on Indexed.vc" width="260" height="76" /></a>